- 2025-04-12 17:49GGTI-286 TFA
- 2025-04-12 17:49Ogalvibart (C-135-LS; BMS-986414) 2599039-60-6
- 2025-04-12 17:49ATN-161 TFA 904763-27-5
- 2025-04-12 17:49Anticancer agent 14 2762698-14-4
- 2025-04-12 17:49Palmitic acid-13C sodium 201612-54-6
- 2025-04-12 17:49Anticancer agent 11 2332936-95-3
- 2025-04-12 17:49Siamycin I (BMY-29304) 164802-68-0
- 2025-04-12 17:49AuM1Gly
- 2025-04-12 17:49AZ31 2088113-98-6
- 2025-04-12 17:49JB062 2417988-00-0
- 2025-04-12 17:49TLR7/8 agonist 4 hydroxy-PEG6-acid 2388520-23-6
- 2025-04-12 17:49Cdc7-IN-3 1402057-87-7
- 2025-04-12 17:49BRD7586 895460-70-5
- 2025-04-12 17:49Eupatoriopicrin 6856-01-5
- 2025-04-12 17:49Boc-Val-Dil-Dap-OH 1415246-54-6
- 2025-04-12 17:491-[3'-O-[(4,4'-Dimethoxytriphenyl)methyl]-aL-threofuranosyl]-N4-benzoylcytosine 325683-91-8
- 2025-04-12 17:49HDAC6-IN-44
- 2025-04-12 17:49Dolastatin 10 trifluoroacetate 2342568-65-2
- 2025-04-12 17:49Heneicosane-d44 (n-Heneicosane-d44) 39756-37-1
- 2025-04-12 17:49Cabazitaxel (XRP-6258; RPR-116258A; taxoid XRP6258) 183133-96-2
